The legacy of Viagra, and its parent company copyright, presents a challenging case study for investors. Initially a blockbuster drug, generating billions in sales , its intellectual property lapse created a https://allyourbookmarks.com/story21430526/sildenafil-and-big-pharma-a-precarious-opportunity